These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24928999)

  • 1. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.
    Voo KS; Bover L; Harline ML; Weng J; Sugimoto N; Liu YJ
    J Immunol; 2014 Jul; 193(2):627-34. PubMed ID: 24928999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
    Pathangey LB; McCurry DB; Gendler SJ; Dominguez AL; Gorman JE; Pathangey G; Mihalik LA; Dang Y; Disis ML; Cohen PA
    Oncotarget; 2017 Feb; 8(7):10785-10808. PubMed ID: 27974697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells.
    Olivier A; Sainz-Perez A; Dong H; Sparwasser T; Majlessi L; Leclerc C
    Eur J Immunol; 2011 Aug; 41(8):2303-13. PubMed ID: 21538349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.
    Narayan S; Kolly L; So A; Busso N
    Immunology; 2011 Sep; 134(1):33-40. PubMed ID: 21718313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
    Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
    J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice.
    Lykken JM; DiLillo DJ; Weimer ET; Roser-Page S; Heise MT; Grayson JM; Weitzmann MN; Tedder TF
    J Immunol; 2014 Jul; 193(2):746-56. PubMed ID: 24928986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.
    Caron G; Duluc D; Frémaux I; Jeannin P; David C; Gascan H; Delneste Y
    J Immunol; 2005 Aug; 175(3):1551-7. PubMed ID: 16034093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of TLR ligand (R-848) and IL-12 on the production of IFN-gamma by human NK cell subsets].
    Yin LF; Fan YY; Li L; Wu CY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):623-6. PubMed ID: 17618583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
    Allan SE; Crome SQ; Crellin NK; Passerini L; Steiner TS; Bacchetta R; Roncarolo MG; Levings MK
    Int Immunol; 2007 Apr; 19(4):345-54. PubMed ID: 17329235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Endothelial Cells Modulate CD4
    Lim WC; Olding M; Healy E; Millar TM
    Front Immunol; 2018; 9():565. PubMed ID: 29628925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human regulatory CD8 T cells.
    Ablamunits V; Bisikirska BC; Herold KC
    Ann N Y Acad Sci; 2008 Dec; 1150():234-8. PubMed ID: 19120302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.
    LaRosa DF; Gelman AE; Rahman AH; Zhang J; Turka LA; Walsh PT
    Immunol Lett; 2007 Feb; 108(2):183-8. PubMed ID: 17270282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.
    Dong H; Rowland I; Tuohy KM; Thomas LV; Yaqoob P
    Clin Exp Immunol; 2010 Aug; 161(2):378-88. PubMed ID: 20456417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
    Winger EE; Reed JL
    Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
    Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.